Relationship between the Asbestos Cumulative Exposure Index (ACEI) and the Latency Period of Asbestos Related Diseases (ARD) within an Italian Study Group of Ex-Asbestos Workers

Objectives: The association between asbestos exposure, measured by mean of Asbestos Cumulative Exposure Index (ACEI) and the latency period of non-malignant asbestos-related diseases (ARD) diagnosed according to the American Thoracic Society (ATS) criteria was studied. Methods: 306 exposed asbestos workers in Bari, Italy, were included in a health surveillance program. By means of a standardized questionnaire we assessed asbestos exposure through ACEI. Latency period of Asbestos Related Diseases (ARD) was also assessed. Results: We found a significant inverse correlation between latency and ACEI increasing with ARD severity. ACEI and 30-35 years of age at time of first exposure were inversely associated with the latency period. The risk of ARD increased from baseline to the 2nd follow-up and among subjects exposed for the first time before 1960. Conclusions: The most important factors that caused a reduction in the latency period were the year of first exposure and the ACEI score while smoking habits did not show to play a significant role.

[1]  D. Loomis,et al.  Prevention of Asbestos-Related Disease in Countries Currently Using Asbestos , 2016, International journal of environmental research and public health.

[2]  C. Roelofs.  Latency attention deficit: Asbestos abatement workers need us to investigate. , 2015, American journal of industrial medicine.

[3]  S. Markowitz.  Asbestos-Related Lung Cancer and Malignant Mesothelioma of the Pleura: Selected Current Issues , 2015, Seminars in Respiratory and Critical Care Medicine.

[4]  Laurie Kazan-Allen,et al.  Asbestos in Asia , 2015, Respirology.

[5]  D. Christiani,et al.  Smoking-associated fibrosis and pulmonary asbestosis , 2014, International journal of chronic obstructive pulmonary disease.

[6]  J. Mezey,et al.  Smoking accelerates aging of the small airway epithelium , 2014, Respiratory Research.

[7]  Eun‐Kee Park,et al.  Asbestos: use, bans and disease burden in Europe , 2014, Bulletin of the World Health Organization.

[8]  Eun‐Kee Park,et al.  Lung Function Profiles among Individuals with Nonmalignant Asbestos-related Disorders , 2014, Safety and health at work.

[9]  G. Naughton,et al.  Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis. , 2014, Chest.

[10]  C. Noonan,et al.  Autoimmunity and Asbestos Exposure , 2014, Autoimmune diseases.

[11]  Mathieu Valcke,et al.  Lung cancer and mesothelioma risk assessment for a population environmentally exposed to asbestos. , 2014, International journal of hygiene and environmental health.

[12]  Deborah H Yates,et al.  Asbestos and the lung in the 21st century: an update , 2014, The clinical respiratory journal.

[13]  G. Frost.  The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005) , 2013, British Journal of Cancer.

[14]  F. Zannol,et al.  Post-occupational health surveillance of asbestos workers. , 2013, La Medicina del lavoro.

[15]  Y. Schwarz,et al.  Continued progression of asbestos-related respiratory disease after more than 15 years of non-exposure. , 2012, The Israel Medical Association journal : IMAJ.

[16]  V. Jeebun,et al.  The presentation and natural history of asbestos-induced diffuse pleural thickening. , 2012, Occupational medicine.

[17]  A. Kane,et al.  Non-Neoplastic and Neoplastic Pleural Endpoints Following Fiber Exposure , 2011, Journal of toxicology and environmental health. Part B, Critical reviews.

[18]  F. Zannol,et al.  Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships. , 2009, American journal of industrial medicine.

[19]  D. Yates,et al.  Journal of Occupational Medicine and Toxicology Clinical Consequences of Asbestos-related Diffuse Pleural Thickening: a Review , 2008 .

[20]  A. Marinaccio,et al.  Asbestos related diseases in Italy: an integrated approach to identify unexpected professional or environmental exposure risks at municipal level , 2008, International archives of occupational and environmental health.

[21]  D. Berman,et al.  Update of Potency Factors for Asbestos-Related Lung Cancer and Mesothelioma , 2008, Critical reviews in toxicology.

[22]  R. Tumino,et al.  [Epidemiological surveillance of malignant mesothelioma cases in Italy: incidence and asbestos exposure figures by the Italian mesothelioma registry (ReNaM)]. , 2007, Epidemiologia e prevenzione.

[23]  B. Cohen.  Test of the Linear-No Threshold Theory: Rationale for Procedures , 2005, Dose-response : a publication of International Hormesis Society.

[24]  D. Postma,et al.  Susceptibility to air pollution in elderly males and females , 2005, European Respiratory Journal.

[25]  T. Ushijima,et al.  No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  A. Burdorf,et al.  Occupational characteristics of cases with asbestos-related diseases in The Netherlands. , 2003, The Annals of occupational hygiene.

[27]  G. Assennato,et al.  [Mortality in a cohort of asbestos cement workers in Bari]. , 2002, Epidemiologia e prevenzione.

[28]  B Terracini,et al.  Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos , 2000, British Journal of Cancer.

[29]  A. Tossavainen.  Asbestos , asbestosis , and cancer : the Helsinki criteria for diagnosis and altribu tion , 2022 .

[30]  M. Huuskonen,et al.  Screening for asbestos-induced diseases in Finland. , 1996, American journal of industrial medicine.

[31]  B. Järvholm.  Pleural plaques and exposure to asbestos: a mathematical model. , 1992, International journal of epidemiology.

[32]  A. Churg,et al.  Effects of cigarette smoke exposure on retention of asbestos fibers in various morphologic compartments of the guinea pig lung. , 1987, The American journal of pathology.

[33]  Buist As.  Standardization of spirometry. , 1987 .

[34]  E. C. Hammond,et al.  Asbestos and smoking. , 1979, JAMA.

[35]  Firm-Andrew J. Beck,et al.  Standard ization of Spirometry-1987 Update ' , 2017 .

[36]  H. Vainio,et al.  Helsinki Criteria update 2014: asbestos continues to be a challenge for disease prevention and attribution. , 2016, Epidemiologia e prevenzione.

[37]  H. Weill,et al.  Diagnosis and initial management of nonmalignant diseases related to asbestos. , 2005, American journal of respiratory and critical care medicine.

[38]  It Istituto Superiore di Sanit,et al.  Linee guida per la rilevazione e la definizione dei casi di mesotelioma maligno e la trasmissione delle informazioni all'Ispesl da parte dei Centri Operativi Regionali. seconda edizione , 2004 .

[39]  Mirjana Vujović,et al.  Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study. , 2003, Croatian medical journal.